financetom
Business
financetom
/
Business
/
Clorox Fiscal Q1 Adjusted Earnings, Revenue Decline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Clorox Fiscal Q1 Adjusted Earnings, Revenue Decline
Nov 3, 2025 1:55 PM

04:44 PM EST, 11/03/2025 (MT Newswires) -- Clorox (CLX) reported fiscal Q1 adjusted earnings late Monday of $0.85 per diluted share, down from $1.86 a year earlier.

Analysts polled by FactSet expected $0.78.

Revenue for the three months ended Sept. 30 was $1.43 billion, down from $1.76 billion a year earlier.

Analysts surveyed by FactSet expected $1.39 billion.

The firm said it is maintaining its fiscal year 2026 outlook for net sales, gross margin and adjusted EPS. It kept its adjusted EPS guidance of $5.95 to $6.30. Analysts expected $5.93.

Shares were up over 3% in extended trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AltaGas Q2 Normalized Net Income Surges on Strong Midstream, Utilities Performance
AltaGas Q2 Normalized Net Income Surges on Strong Midstream, Utilities Performance
Aug 1, 2025
06:36 AM EDT, 08/01/2025 (MT Newswires) -- AltaGas ( ATGFF ) on Friday said second-quarter normalized net income doubled, driven by strong performance in its midstream and utilities segments. Normalized net income was $81 million, or $0.27 per share, up from $41 million, or $0.14 per share. Normalized EBITDA also rose to $342 million from $295 million. A 23% increase...
US plans Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports
US plans Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports
Aug 1, 2025
Aug 1 (Reuters) - The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Friday, citing documents from the Centers for Medicare and Medicaid Services. GLP-1 drugs, originally developed for type 2 diabetes, have gained popularity for their ability to reduce body weight by suppressing appetite and slowing digestion. But...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Kleenex tissue maker Kimberly-Clark's quarterly sales jump on strong demand
Kleenex tissue maker Kimberly-Clark's quarterly sales jump on strong demand
Aug 1, 2025
(Reuters) -Kimberly-Clark on Friday posted a rise in second-quarter organic sales and beat profit estimates, led by steady demand for products such as Huggies diapers and Kleenex tissues in domestic and international markets. The Dallas-based firm has broadened its portfolio to offer products from budget to premium price tiers, in an effort to capture demand across income levels and combat...
Copyright 2023-2026 - www.financetom.com All Rights Reserved